# Validation of an Adjusted Dosing Algorithm of Carboplatin

> **NCT02103244** · PHASE4 · UNKNOWN · sponsor: **Rijnstate Hospital** · enrollment: 24 (estimated)

## Conditions studied

- Cancer

## Interventions

- **DRUG:** Carboplatin

## Key facts

- **NCT ID:** NCT02103244
- **Lead sponsor:** Rijnstate Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-09
- **Primary completion:** 2015-09
- **Final completion:** 2015-12
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2014-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02103244

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02103244, "Validation of an Adjusted Dosing Algorithm of Carboplatin". Retrieved via AI Analytics 2026-06-21 from https://api.ai-analytics.org/clinical/NCT02103244. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*